• 1
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155: 11511164.
  • 2
    Shevach EM. CD4+CD25+ suppressor T cells: many questions than answers. Annu Rev Immunol 2002;2: 389400.
  • 3
    Bluestone JA, Abbas AK. Natural vs adaptive regulatory T cells. Nat Rev Immunol 2003;3: 253257.
  • 4
    Cosmi L, Liotta F, Lazzeri E, Francalanci M, Angeli R, Mazzinghi B et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003;102: 41074114.
  • 5
    Bienvenu B, Martin B, Auffray C, Cordier C, Becourt C, Lucas B. Peripheral CD8(+)CD25(+) T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 2005;175: 246253.
  • 6
    Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265: 12371240.
  • 7
    Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001;182: 6879.
  • 8
    Baecher-Allen C, Wolf E, Hafler DA. Functional analysis of highly defined, FACS isolated populations of human regulatory CD4+CD25+ T cells. Clin Immunol 2005;115: 1018.
  • 9
    Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, Vanini V et al. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med 2002;196: 379387.
  • 10
    Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192: 295302.
  • 11
    Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 2004;34: 613622.
  • 12
    Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G et al. Role of LAG-3 in regulatory T cells. Immunity 2004;21: 503513.
  • 13
    Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299: 10571061.
  • 14
    Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000;106: R75R81.
  • 15
    Godfrey VL, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 1991;138: 13791387.
  • 16
    Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whiteself L et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of Foxp3. Nat Genet 2001;27: 2021.
  • 17
    Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004;34: 623630.
  • 18
    Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, Ling KL et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005;35: 16811691.
  • 19
    Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005;66: 1320.
  • 20
    Stockinger B, Barthlott T, Katassis G. T cell regulation: a special job or everyone's responsibility? Nat Immunol 2001;2: 757758.
  • 21
    Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4: 330336.
  • 22
    Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005;105: 11621169.
  • 23
    Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by surface-bound transforming growth factor β. J Exp Med 2001;194: 629644.
  • 24
    Cosmi L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R et al. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 2004;103: 31173121.
  • 25
    Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H et al. CD4+CD25+ T cells can mediate suppressor function in the absence of transforming growth factor-β1production and responsiveness. J Exp Med 2002;196: 237245.
  • 26
    Chen W, Wahl SM. TGF-β: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev 2003;14: 8589.
  • 27
    Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and induced CD4+ CD25+ cells educate CD4+ CD25- cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J Immunol 2004;172: 52135221.
  • 28
    Fahlen L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA et al. T cells that cannot respond to TGF-β escape control by CD4+ CD25+ regulatory T cells. J Exp Med 2005;201: 737746.
  • 29
    Chen W, Jin W, Hardegen N, Lei K-J, Li L, Marinos N et al. Conversion of peripheral CD4+CD2- naïve T cells to CD4+CD25+ regulatory T cells bt TGF-b induction of transcription factor Foxp3. J Exp Med 2003;198: 18751886.
  • 30
    Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D et al. Tgf-b induces Foxp3+ T-regulatory cells from naive CD4+CD25+ precursors. Am J Transplant 2004;4: 16141627.
  • 31
    Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C et al. TGF-β signalling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+ CD25+ T cells. J Immunol 2004;173: 65266531.
  • 32
    Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGFβ1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005;201: 10611067.
  • 33
    Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163: 10371050.
  • 34
    Massague J. TGF-β signal transduction. Annu Rev Biochem 1998;67: 753791.
  • 35
    Roberts AB. The ever-increasing complexity of TGF-b signalling. Cytokine Growth Factor Rev 2002;13: 35.
  • 36
    Nocentini G, Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 2005;35: 10161022.
  • 37
    Cerotto de La faille MA, Muriglan S, Sunshine M-J, Lei Y, Kutchukhidze N, Furtado GC et al. Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J Exp Med 2001;194: 13491359.
  • 38
    Kanangat S, Blair P, Reddy R, Daheshia M, Godfrey V, Rouse BT et al. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur J Immunol 1996;26: 161165.
  • 39
    Ling EM, Smith T, Nguyen XD, Pridgein C, Dallman M, Arbery J et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation in atopic status and expression of allergic disease. Lancet 2004;363: 608615.
  • 40
    Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199: 15671575.
  • 41
    Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004;199: 16791688.
  • 42
    Turcanu V, Maleki SJ, Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest 2003;111: 10651072.
  • 43
    Akdis CA , Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin-10 in specific immunotherapy. J Clin Invest 1998;102: 98106.
  • 44
    Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003;111: 12551261.
  • 45
    Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004;113: 10251034.
  • 46
    Strachan DP. Hay fever, hygiene and household size. Br Med J 1989;299: 12591260.
  • 47
    Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waswer M, Grize L et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347: 869877.
  • 48
    Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004;113: 395400.
  • 49
    Yazdanbakhah M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002;296: 490494.
  • 50
    Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347: 911920.
  • 51
    Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004;112: 352363.
  • 52
    Revets H, Pynaert G, Grooten J, De Baetselier P. Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune response. J Immunol 2005;174: 10971103.
  • 53
    Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune response. Cell 2005;122: 107118.
  • 54
    Skapenko A, Niedobitek GU, Kalden JR, Lipsky PE, Schulze-Koops H. IL-4 exerts a much more profound suppression of Th1 immunity in humans than in mice. J Immunol 2004;172: 64276434.
  • 55
    King IL, Segal BM. IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells. J Immunol 2005;175: 641645.
  • 56
    Stock P, Akbari O, Berry G, Freeman GJ, DeKruyff RH, Umetsu DT. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004;5: 11491156.
  • 57
    Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G et al. Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177: 11991204.
  • 58
    Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS et al. Reciprocal regulatory role of IFN-g and IL-4 on the in vitro development of human Th1 and Th2 cells. J Immunol 1992;148: 21422147.
  • 59
    Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP et al. IL-4 and IFN(s) (alpha and gamma) exhibit opposite regulatory effects on the development of cytolytic potential by TH1 or TH2 human T cell clones. J Immunol 1992;149: 29772982.
  • 60
    Manetti R, Annunziato F, Tomasevic L, Gianno V, Parronchi P, Romagnani S et al. Polyinosinic acid:polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol 1999;25: 26562660.
  • 61
    Parronchi P, Brugnolo F, Annunziato F, Manuelli C, Sampognaro S, Mavilia C et al. Phosphorothioate oligodeoxynucletides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors. J Immunol 1999;163: 59465953.
  • 62
    Brugnolo F, Sampognaro S, Fintoni T, Cosmi L, Annunziato F, Manuelli C et al. The novel synthetic immune response modifier R-848 (Resiquimod) has a powerful effect on the in vitro switching of human allergen-specific CD4+ Th2 lymphocytes into IFN-γ-producing cells. J Allergy Clin Immunol 2003;111: 380388.
  • 63
    Annunziato F, Cosmi L, Manetti R, Brugnolo F, Parronchi P, Maggi E et al. Reversal of human allergen-specific CRTH2+ Th2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J Allergy Clin Immunol 2001;108: 815821.
  • 64
    Marshall JD, Abtahi S, Eiden JJ, Tuck S, Milley R, Haycock F et al. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001;108: 191197.
  • 65
    Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004;4: 110.
  • 66
    Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106: 124134.
  • 67
    Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004;113: 235241.
  • 68
    Simons FE, Shikishima Y, Van Nest G, Eiden JJ, HayGlass KT. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol 2004;113: 11441151.
  • 69
    Lazarczyk M, Grzela K, Grzela T. Immmunostimulatory oligonucleotides in therapy of allergic diseases. Expert Opin Biol Ther 2005;5: 525536.
  • 70
    Walker LS, Chrodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+CD25+ regulatory T cells. J Exp Med 2003;198: 249258.
  • 71
    Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med 2000;342: 13501358.
  • 72
    Elias JA, Xhu Z, Chupp G, Homer RJ. Airway remodelling in asthma. J Clin Invest 1999;104: 10011006.
  • 73
    Hawylowicz CM, O'Garra A. Potential role of interleukin-10 secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005;5: 271283.
  • 74
    Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha RS. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 2003;112: 10581066.
  • 75
    Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy – review of a new approach. Pharmacol Rev 2003;55: 241269.
  • 76
    Penna G, Giarratana N, Amuchastegui S, Mariani R, Daniel KC, Adorini L. Manipulating dendritic cells to induce regulatory T cells. Microbes Infect 2005;7: 10331039.
  • 77
    Richards DF, Fernandez M, Caulfield J, Hawrylowicz CM. Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur J Immunol 2000;30: 23442354.
  • 78
    Hawrylowicz C. Correction of the defect in glucocorticoid-induced IL-10 synthesis in T cells from glucocorticoid resistant asthmatic patients. J Allergy Clin Immunol 2004;113(Suppl.):A735.
  • 79
    Kalliomaki M, Salminen S, Poussa T, Avilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361: 18691871.
  • 80
    Zuani-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002;8: 625629.
  • 81
    Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol 2004;114: 131136.
  • 82
    Prioult G, Nagler-Anderson C. Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation? Immunol Rev 2005;206: 204218.
  • 83
    Larche M, Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005;11: 569576.
  • 84
    Oldfield WL, Larche M, Kay AB. Effects of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002;360: 4753.